The newspaper La Vanguardia publishes on Sunday, October 7th, an opinion article written by the IDIBELL general manager, Emilià Pola, on the future of the research and development in the world and in Catalonia. Pola highlights that “every biomedical researcher makes possible a business of 400,000 euros per year, five times more than it costs”. The centre’s general manager also noted that “this estimation does not include perhaps the most important impact it has on our lives: to have a vaccine, an antibiotic or an anti-tumor drug”.